ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2277

Perspectives of Female Patients with Rheumatic Diseases Regarding Pregnancy Planning with Rheumatologists

Tierney Wolgemuth 1, Mehret Birru Talabi 1, Alaina Chodoff 2, Sonya Borrero 3 and Mehret Talabi1, 1University of Pittsburgh, Pittsburgh, PA, 2UPMC, Pittsburgh, 3University of Pittsburgh, Pittsburgh

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: family planning and Reproductive Health, pregnancy, qualitative

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Women with rheumatic diseases may be at greater risk for adverse maternal, perinatal, and pregnancy outcomes.  The American College of Rheumatology recommends that female patients who are contemplating pregnancy should discuss their individual pregnancy risks with rheumatologists. Little is known about patients’ information priorities and preferences for such information, or their general attitudes about pregnancy planning in the rheumatology outpatient setting.

Methods: : Female patients ages 18-45 with at least one rheumatic disease were recruited to participate in semi-structured qualitative interviews that explored their priorities and preferences related to reproductive health care. Recruitment occurred in outpatient rheumatology clinics in Pittsburgh, PA. Interviews were conducted via telephone, and were audio-recorded and transcribed verbatim. A code book was inductively developed based on transcript content. Two coders applied the code book to all transcripts (Cohen’s Kappa= 0.69), and coding differences were adjudicated to full agreement. The finalized coding was used to conduct a thematic analysis.

Results: Interviews were conducted among 30 women, who were 35.1 years old on average (S.D. 5.84);  52% were married, 53% had children, and 73% were white. The most common diagnoses included rheumatoid arthritis (23% of sample), systemic lupus erythematosus (23%), Sjogren’s syndrome (17%), undifferentiated connective tissue disorder (10%), and spondyloarthritis (7%). Five themes emerged: 1) Women wanted rheumatologists to initiate conversations about family planning repeatedly over time; 2) Women desired clear and complete information from rheumatologists regarding fetal, pregnancy, and infertility risks associated with their diseases and disease-modifying anti-rheumatic drugs (DMARDs);  3) Women wanted to be treated holistically, with family planning issues addressed in the context of their life circumstances and personal values as well as their diseases; 4) Women were reluctant to continue any DMARDs during pregnancy, even if compatible with pregnancy;  5) Women felt that they were often intermediaries between their rheumatologists and obstetrician-gynecologists (ObGyns), but preferred for their rheumatologists to communicate directly with their ObGyns in advance of and during pregnancy. Illustrative quotations are presented in Table 1.

Conclusion: Patients strongly desired for rheumatologists to play an active and continuous role in their family planning care. Patients specifically want for their rheumatologists to provide education, review DMARD- and disease-related risks related to pregnancy, and communicate directly with ObGyns before and during pregnancy to optimize a woman’s chances for a healthy pregnancy. Prior studies indicate that family planning rarely occurs in the rheumatology outpatient setting; our results further suggest that some women with rheumatic diseases do not receive the family planning care that they desire.  Further work is needed to clarify the role of rheumatologists in family planning, and how to enhance communication between rheumatologists and other women’s healthcare professionals.


Table 1

Table 1. Themes and Representative Quotations


Disclosure: T. Wolgemuth, None; M. Birru Talabi, None; A. Chodoff, None; S. Borrero, None; M. Talabi, None.

To cite this abstract in AMA style:

Wolgemuth T, Birru Talabi M, Chodoff A, Borrero S, Talabi M. Perspectives of Female Patients with Rheumatic Diseases Regarding Pregnancy Planning with Rheumatologists [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/perspectives-of-female-patients-with-rheumatic-diseases-regarding-pregnancy-planning-with-rheumatologists/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perspectives-of-female-patients-with-rheumatic-diseases-regarding-pregnancy-planning-with-rheumatologists/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology